Alliance for Family Integrated Care Implementation in Neonatal Intensive Care Units
- Conditions
- Preterm
- Interventions
- Procedure: FICare
- Registration Number
- NCT06087666
- Brief Summary
International, multi-centre, pluri-cultural, stepped wedge cluster controlled trial, to demonstrate superiority of site tailored 'Family integrated care model'(FICare), that promotes the active participation of the parents as primary caregivers of their infants in neonatal intensive care units (NICU), versus standard NICU care delivery with regards to short-term health outcomes in high-risk newborns with prolonged hospital stay.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 12
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description FICare intervention FICare FICare implementation model will be demonstrated by setting 5 pilots in non-FICare-experienced NICUs from NL, TR, RO, UK, ZM (AMC, GU, CLUJ, UHS, and UNZA, partners, respectively) and 2 pilots in clinical sites who have recently implemented FICare from ES and NL (SERMAS and OLVG).
- Primary Outcome Measures
Name Time Method RISEinFAMILY implementation: Through study completion (average of 24 months) Average time of kangaroo care per day
Short-term health infant's outcomes Through study completion (average of 24 months) proportion of high-risk infants achieving and maintaining adequate growth patterns during NICU admission.
- Secondary Outcome Measures
Name Time Method Feeding patterns at discharge: Through study completion (average of 24 months) postmenstrual age (PMA) at discharge
Parental psychological health Through study completion (average of 24 months) Resilience will be measured Brief Resilience Scale. Scale ranges from 0 yo 6. For items 4, 7, 9, 12, 17, 18, 19 and 21, higher scores indicate a better outcome. For items 1, 2, 3, 5, 6, 8, 10, 11, 13, 14, 15, 16m 20 and 22 a higher score indicates a worse outcome.
Proportion of infants diagnosed of (at 36 weeks PMA or discharge): bronchopulmonary dysplasia, oxygen dependency, severe retinopathy of prematurity (grade 3 or need for treatment), nosocomial infection necrotising enterocoli Through study completion (average of 24 months) Reported adverse event rate per 1000 patients/day Through study completion (average of 24 months) Brestfeeding rates at discharge: Through study completion (average of 24 months) Number of patients with \>50% of intake
Satisfaction and self-care of professionals measured by surveys Through study completion (average of 24 months) Work and wellbeing will be measured using Unwes-9 work and well-being survey (UWES).
Scale ranges from 0 to 6, a higher score indicates a better outcome
Trial Locations
- Locations (2)
Hospital Universitario La Paz
🇪🇸Madrid, Spain
Gazi University
🇹🇷Ankara, Turkey